Jean-François Courtet, who has been leading the Tunisian affiliate of Novo Nordisk as general manager for three years, discusses the prevalence of diabetes and lack of awareness thereof in Tunisia, the company’s ambition to launch a series of new products to the market, and Novo Nordisk’s continuing dedication to the Libyan market and its patients.
What defines the Tunisian market for Novo Nordisk and what place does the company occupy in it?
"I am very satisfied with how far we have come in Tunisia, and I was able to implement all changes and reforms in order to bring the affiliate back on a sustainable growth track."
